Mallinckrodt hit with new kickback charges same day as $15.4M settlement with the feds

Chafing under federal kickback charges tied to controversial opioid gel H.P. Acthar, Mallinckrodt appeared to be out of the woods with a settlement in the works. Turns out it was out of the frying pan and into the fire.

The DOJ filed new charges Wednesday against Mallinckrodt, which acquired Acthar-maker Questcor Pharma in 2014, accusing the company of funneling money through front funds to illegally subsidize Medicare copays and jack up the drug’s list price 85,000%.